参松养心胶囊联合胺碘酮治疗对室性心律失常患者心功能及NT-proBNP水平的影响

Impact of Shensong Yangxin Capsules Combined with Amiodarone on Cardiac Function and NT-proBNP Levels in Patients with Ventricular Arrhythmia

目的探讨参松养心胶囊联合胺碘酮治疗对室性心律失常(VA)患者心功能及NT-proBNP水平的影响。方法选取2020年10月至2021年9月收治的104例VA患者,随机分为观察组(n=52)与对照组(n=52)。对照组采用胺碘酮治疗,观察组在对照组基础上采用参松养心胶囊治疗,比较两组的心功能指标及NT-proBNP水平。结果治疗后,两组室性早搏次数、QTd低于治疗前,LVEF高于治疗前,且观察组室性早搏次数、QTd低于对照组,LVEF高于对照组(P<0.05)。治疗后,两组的NT-proBNP水平均低于治疗前,且观察组NT-proBNP水平低于对照组(P<0.05)。结论参松养心胶囊联合胺碘酮治疗可明显改善VA患者的心功能指标,调节NT-proBNP水平,值得推广。

Objective To explore the impact of Shensong Yangxin capsules combined with amiodarone on cardiac function and NT-proBNP levels in patients with ventricular arrhythmia(VA).Methods 104 VA patients from October 2020 to September 2021 were randomly divided into observation group(n=52)and control group(n=52).The control group was treated with amiodarone,and the observation group was treated with Shensong Yangxin capsules on the basis of the control group.The cardiac function indicators and NT-proBNP levels were compared between the two groups.Results After treatment,the times of ventricular premature beats and QTd in both groups were lower than those before treatment,and the LVEF was higher than that before treatment(P<0.05);The times of ventricular premature beats and QTd in the observation group were lower than those in the control group,and the LVEF was higher in the the control group(P<0.05).After treatment,the NT-proBNP levels in both groups were lower than those before treatment,and the NT-proBNP level in observation group was lower in the control group(P<0.05).Conclusions Shensong Yangxin capsules combined with amiodarone can significantly improve the cardiac function indicators and regulate the NT-proBNP level in VA patients,which is worthy of promotion.